scholarly journals The Effects of Preoperative18F-FDG PET/CT in Breast Cancer Patients in Comparison to the Conventional Imaging Study

2012 ◽  
Vol 15 (4) ◽  
pp. 441 ◽  
Author(s):  
Young Jin Choi ◽  
Young Duck Shin ◽  
Yoon Hee Kang ◽  
Moon Soo Lee ◽  
Min Koo Lee ◽  
...  
2006 ◽  
Vol 33 (7) ◽  
pp. 785-791 ◽  
Author(s):  
C. Rousseau ◽  
E. Bourbouloux ◽  
L. Campion ◽  
N. Fleury ◽  
B. Bridji ◽  
...  

2009 ◽  
Vol 12 (3) ◽  
pp. 163
Author(s):  
Yong Hun Kim ◽  
Jin Sun Lee ◽  
Chul Joo Lee ◽  
Je Ryong Kim ◽  
Eil Sung Chang

BMC Cancer ◽  
2020 ◽  
Vol 20 (1) ◽  
Author(s):  
In Hee Lee ◽  
Soo Jung Lee ◽  
Jeeyeon Lee ◽  
Jin Hyang Jung ◽  
Ho Yong Park ◽  
...  

Abstract Background Pathologic complete response (pCR) after neoadjuvant chemotherapy (NAC) is a predictor of improved outcomes in breast cancer. In patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2) -negative breast cancer, the response to NAC is variable and mostly limited. This study was an investigation of the predictive relevance of parameters of 18F-FDG PET/CT for the pCR to NAC in patients with HR-positive, HER2–negative breast cancer. Methods: AH total of 109 consecutive HR-positive and HER2-negative breast cancer patients who were treated with NAC were enrolled in this prospective cohort study. The relationships between pretreatment 18F-FDG PET/CT and clinical outcomes including pathologic response to NAC were evaluated. Results: All patients finished their planned NAC cycles and eight patients (7.3%) achieved pCR. In the receiver operating characteristic (ROC) curve analysis, pSUVmax exhibited high sensitivity and specificity for predicting pCR. Furthermore, multivariate logistic regression analysis revealed pSUVmax as a predictive factor for pCR (hazard ratio = 17.452; 95% CI = 1.847–164.892; p = 0.013). Conclusion The results of this study suggest that 18F-FDG PET/CT pSUVmax is a predictive factor for pCR of HR-positive, HER2-negative breast cancer to NAC.


2018 ◽  
Vol 8 (1) ◽  
Author(s):  
Daniëlle Koopman ◽  
Jorn A. van Dalen ◽  
Hester Arkies ◽  
Ad H. J. Oostdijk ◽  
Anne Brecht Francken ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document